CYTOKERATIN POSITIVITY IN FINE-NEEDLE ASPIRATES OF MELANOMAS AND SARCOMAS

被引:15
作者
BANKS, ER
JANSEN, JF
OBERLE, E
DAVEY, DD
机构
[1] Division of Cytopathology, Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center and VA Medical Center, Lexington, Kentucky
关键词
CYTOKERATIN; MELANOMAS; SARCOMAS; NEOPLASMS;
D O I
10.1002/dc.2840120307
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Cytokeratin (CK) positivity has been considered a specific marker for epithelial differentiation in cytologic specimens. After observing CK reactivity in fine-needle aspirate (FNA) specimens of melanoma and sarcoma, a retrospective study of melanomas and sarcomas was undertaken to investigate the frequency of anomalous CK staining in these neoplasms. Cell block sections and/or restrained smears from 36 melanomas and sarcomas were retrospectively stained for CK. An appropriate internal positive control (HMB-45, S100 protein, or vimentin) was also used to insure antigen preservation. Of the smears from 19 melanomas, five revealed focal strong CK positivity of neoplastic cells, two cases showed faint or equivocal staining, 11 cases were negative for CK, and one could not be interpreted due to inadequate controls. Of the smears from 14 sarcomas, two showed positivity for CK (one fibrosarcoma and one condrosarcoma), 11 were negative, and one had inadequate controls. The number of CK positive cells was less than that observed with the appropriate internal positive control antibodies. Destained Papanicolaou smears were superior to Diff-Quik smears for retrospective immunocytochemical stains. Cell block sections from four of the melanomas and one sarcoma demonstrated no aberrant staining. Since cytokeratin positivity occasionally is seen in nonepithelial neoplasms, its presence alone cannot be used to make a definitive diagnosis of carcinoma. Therefore, a panel of immunocytochemical stains should be utilized in diagnosis of FNA specimens. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:230 / 233
页数:4
相关论文
共 18 条
[1]  
Litzky LA, Brooks JJ, Cytokeratin immunoreactivity in malignant fibrous histiocytoma and spindle cell tumors: comparison between frozen and paraffin‐embedded tissues, Mod Pathol, 5, pp. 30-34, (1992)
[2]  
Miettinen M, Rapola J, Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma‐like tumors. Expression of cytokeratin and the 68‐kD neurofilament protein, Am J Surg Pathol, 13, pp. 120-132, (1989)
[3]  
Parham DM, Webber B, Holt H, Williams WK, Maurer H, Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an intergroup rhabdomyosarcoma study project, Cancer, 67, pp. 3072-3080, (1991)
[4]  
Rosenberg AE, O'Connell JX, Dickersin GR, Bhan AK, Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study, Hum Pathol, 24, pp. 284-293, (1993)
[5]  
Chase DR, Enzinger FM, Weiss SW, Langloss JM, Keratin in epithelioid sarcoma: an immunohistochemical study, Am J Surg Pathol, 8, pp. 435-441, (1984)
[6]  
Corson JM, Weiss LM, Banks-Schlegel SP, Pinkus GS, Keratin proteins in synovial sarcoma, Am J Surg Pathol, 7, pp. 107-109, (1983)
[7]  
Miettinen M, Franssila K, Immunohistochemical spectrum of malignant melanoma. The common presence of keratins, Lab Investigation, 61, pp. 623-628, (1989)
[8]  
Zarbo RJ, Gown AM, Nagle RB, Visscher DW, Crissman JD, Anomalous cytokeratin expression in malignant melanoma: one‐and two‐dimensional western blot analysis and immunohistochemical survey of 100 melanomas, Mod Pathol, 3, pp. 494-501, (1990)
[9]  
Nasiell K, Tani E, Skoog L, Fine needle aspiration cytology and immunocytochemistry of metastatic melanoma, Cytopathology, 2, pp. 137-147, (1991)
[10]  
Pettigrew NM, Techniques in immunocytochemistry. Application to diagnostic pathology, Arch Pathol Lab Med, 113, pp. 641-644, (1989)